COVID-19 vaccine manufacturing, supply and administration programs

This is a preview of subscriber content

Subscribe now to continue reading.

The US administered another 1.5 million doses on Saturday - a total of 20.5 million doses have now been administered in the country. Over 63 million doses have been administered globally and more than 55 countries have now launched national immunisation programs. Pfizer and AstraZeneca have reduced the number of vaccines doses expected to be delivered to the European Union in the first quarter of 2021. …

Subscribe now to continue reading.

COVID-19 vaccine manufacturing, supply and administration programs

This is a preview of subscriber content

Latest Video

Most Read

Officials talk down the prospect of MFN impact on the PBS

An exchange that reveals the truth of a review that has now become a lot like 'Weekend at Bernie's'

Invitation confusion clouds Delphi studies and captures medical device sector

Officials confirm shift in Budget management of underspends

A clear disconnect between the public and private on 'Most Favored Nation' pricing

New Stories

Opthea returns to ASX and works to restart eye therapy candidate

A clear disconnect between the public and private on 'Most Favored Nation' pricing

New blueprint charts a potential policy path forward on biosimilars

Officials cite company consultation, system changes, and spending approvals to justify delay

Novo Nordisk's Marie Krogh Prize returns and crosses the Tasman to back early career women in science

Study confirms pharmacist led care expands timely access to urinary tract infection treatment and contraception

Officials talk down the prospect of MFN impact on the PBS

Sign In

COVID-19 vaccine manufacturing, supply and administration programs

This is a preview of subscriber content

Latest Video

Most Read

Officials talk down the prospect of MFN impact on the PBS

An exchange that reveals the truth of a review that has now become a lot like 'Weekend at Bernie's'

Invitation confusion clouds Delphi studies and captures medical device sector

Officials confirm shift in Budget management of underspends

A clear disconnect between the public and private on 'Most Favored Nation' pricing

Follow Us

New Stories

Opthea returns to ASX and works to restart eye therapy candidate

A clear disconnect between the public and private on 'Most Favored Nation' pricing

New blueprint charts a potential policy path forward on biosimilars

Officials cite company consultation, system changes, and spending approvals to justify delay

Novo Nordisk's Marie Krogh Prize returns and crosses the Tasman to back early career women in science

Study confirms pharmacist led care expands timely access to urinary tract infection treatment and contraception

Officials talk down the prospect of MFN impact on the PBS